Literature DB >> 15658603

Induction of coronary arteritis with administration of CAWS (Candida albicans water-soluble fraction) depending on mouse strains.

Noriko Nagi-Miura1, Yuko Shingo, Yoshiyuki Adachi, Akiko Ishida-Okawara, Toshiaki Oharaseki, Kei Takahashi, Shiro Naoe, Kazuo Suzuki, Naohito Ohno.   

Abstract

The intraperitoneal administration of CAWS (water-soluble extracellular polysaccharide fraction obtained from the culture supernatant of Candida albicans) to mice induces coronaritis similar to Kawasaki disease. We analyzed differences in the production of cytokines involved in the occurrence of coronary arteritis among mouse strains, C3H/HeN, C57BL/6, DBA/2 and CBA/J that were injected with CAWS at 4 mg/mouse for 5 consecutive days in the first week and the fifth week of administration. The incidence of arteritis was 100% in C57BL/6, C3H/HeN and DBA/2 mice, but only 10% in CBA/J mice. The coronary arteritis observed in DBA/2 mice was the most serious, with several mice expiring during the observation period. The CAWS-sensitive strains revealed increased levels of IL-6 and IFN-gamma during the course of a specific response to CAWS by spleen cells. In contrast, IL-10 levels were observed to increase markedly in CAWS-resistant CBA/J mice, but not the CAWS-sensitive strains. However, TNF-alpha levels were more elevated only in DBA/2 mice. The difference in disease development and cytokine production strongly suggests that the genetic background of the immune response to CAWS contributes to the occurrence of coronary arteritis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15658603     DOI: 10.1081/iph-200042295

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  15 in total

1.  Animal models of vasculitides.

Authors:  Uriel Katz; Boris Gilburd; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

2.  Remarks on the Asia Pacific Meeting of Vasculitis and ANCA Workshop 2012.

Authors:  Kazuo Suzuki
Journal:  Clin Exp Nephrol       Date:  2013-04-25       Impact factor: 2.801

3.  Pathogenic characterization of a cervical lymph node derived from a patient with Kawasaki disease.

Authors:  Harutaka Katano; Seiichi Sato; Tsuyoshi Sekizuka; Akiko Kinumaki; Hitomi Fukumoto; Yuko Sato; Hideki Hasegawa; Shigeru Morikawa; Masayuki Saijo; Tetsuya Mizutani; Makoto Kuroda
Journal:  Int J Clin Exp Pathol       Date:  2012-10-01

4.  Mizoribine provides effective treatment of sequential histological change of arteritis and reduction of inflammatory cytokines and chemokines in an animal model of Kawasaki disease.

Authors:  Kei Takahashi; Toshiaki Oharaseki; Tomokazu Nagao; Yuki Yokouchi; Hitomi Yamada; Noriko Nagi-Miura; Naohito Ohno; Tsutomu Saji; Tomio Okazaki; Kazuo Suzuki
Journal:  Pediatr Rheumatol Online J       Date:  2011-09-29       Impact factor: 3.054

5.  A Model of Left Ventricular Dysfunction Complicated by CAWS Arteritis in DBA/2 Mice.

Authors:  Naoto Hirata; Ken-Ichi Ishibashi; Tatsuya Usui; Jiro Yoshioka; Satoru Hata; Yoshiyuki Adachi; Noriko Nagi-Miura; Shin Ohta; Naohito Ohno
Journal:  Int J Vasc Med       Date:  2012-07-08

6.  Important role of CCR2 in a murine model of coronary vasculitis.

Authors:  Hernan G Martinez; Marlon P Quinones; Fabio Jimenez; Carlos Estrada; Kassandra M Clark; Kazuo Suzuki; Noriko Miura; Naohito Ohno; Sunil K Ahuja; Seema S Ahuja
Journal:  BMC Immunol       Date:  2012-10-17       Impact factor: 3.615

7.  CDCP1 on Dendritic Cells Contributes to the Development of a Model of Kawasaki Disease.

Authors:  Yu Lun; Nozha Borjini; Noriko N Miura; Naohito Ohno; Nora G Singer; Feng Lin
Journal:  J Immunol       Date:  2021-06-07       Impact factor: 5.426

8.  Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis.

Authors:  Akiko Kinumaki; Tsuyoshi Sekizuka; Hiromichi Hamada; Kengo Kato; Akifumi Yamashita; Makoto Kuroda
Journal:  Front Microbiol       Date:  2015-08-11       Impact factor: 5.640

9.  CAWS administration increases the expression of interferon γ and complement factors that lead to severe vasculitis in DBA/2 mice.

Authors:  Noriko Nagi-Miura; Daisuke Okuzaki; Kosuke Torigata; Minami A Sakurai; Akihiko Ito; Naohito Ohno; Hiroshi Nojima
Journal:  BMC Immunol       Date:  2013-09-24       Impact factor: 3.615

10.  Non-Typhoidal Salmonella and the Risk of Kawasaki Disease: A Nationwide Population-Based Cohort Study.

Authors:  Thomas Yen-Ting Chen; Mei-Chia Chou; Jung-Nien Lai; Lu-Ting Chiu; Renin Chang; Yao-Min Hung; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.